These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2657346)

  • 21. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
    Gagliotti C; Nobilio L; Milandri M; Moro ML;
    Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
    Betriu C; Casado MC; Gómez M; Sanchez A; Palau ML; Picazo JJ
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in frequency of serious group A streptococcal infections.
    Rudensky B; Isaacson M; Beck A; Greenfield J
    Isr J Med Sci; 1992 Oct; 28(10):752-3. PubMed ID: 1399515
    [No Abstract]   [Full Text] [Related]  

  • 24. Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.
    Urbánek K; Kolár M; Cekanová L
    Pharm World Sci; 2005 Apr; 27(2):104-7. PubMed ID: 15999920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group A streptococci. Erythromycin resistance and penicillin tolerance.
    Savoia D; Millesimo M; Dotti G; Milano F
    Adv Exp Med Biol; 1997; 418():447-9. PubMed ID: 9331690
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
    Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
    Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between differences in 16-, 14-, and 15-membered ring macrolides and Streptococcus pyogenes resistance.
    Braga PC
    Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):146-8. PubMed ID: 11939399
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin resistant Streptococcus pyogenes in Cambridge.
    Walker M; Whetstone RJ; Whipp J
    J Infect; 1984 Jan; 8(1):88-9. PubMed ID: 6366072
    [No Abstract]   [Full Text] [Related]  

  • 30. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
    Cornaglia G; Ligozzi M; Mazzariol A; Masala L; Lo Cascio G; Orefici G; Fontana R
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S87-92. PubMed ID: 9710676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi drug resistance in group A hemolytic streptococci in Japan from 1972 to 1977.
    Yamada T; Kosakai N
    Jpn Circ J; 1980 Oct; 44(10):801-3. PubMed ID: 7001083
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythromycin resistance in group A streptococci.
    Järvinen H; Nissinen A; Huovinen P
    Lancet; 1989 May; 1(8645):1022-3. PubMed ID: 2565500
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serotyping and antibiotic susceptibility of group A hemolytic Streptococcus isolated in 1978-80: decline of erythromycin resistance].
    Fujita K; Iseki K; Yoshioka H; Maruyama S; Sanae N; Maekawa S; Yamaguchi T
    Kansenshogaku Zasshi; 1983 Sep; 57(9):776-82. PubMed ID: 6421954
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.
    Avanzini C; Bosio K; Volpe G; Dotti G; Savoia D
    Microb Drug Resist; 2000; 6(4):289-95. PubMed ID: 11272257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 37. Group A beta-hemolytic streptococcal pharyngitis resistant to erythromycin: case report.
    Boulter MJ
    Mil Med; 1982 Jan; 147(1):62-3. PubMed ID: 6806686
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of throat cultures in adolescents taking daily antibiotics for acne.
    Dajani AS
    Pediatr Infect Dis J; 1994 Sep; 13(9):842-3. PubMed ID: 7808867
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of antimicrobial agents and drug resistance.
    Swartz MN
    N Engl J Med; 1997 Aug; 337(7):491-2. PubMed ID: 9250853
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.